Q4 2022 Holdings
Filed 2023-02-15 | 22 holdings | $109.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $38.1M | 367,765 | 34.9% |
| Dexcom Inc(DXCM) | COM | 252131107 | $36.4M | 321,380 | 33.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $7.5M | 164,440 | 6.9% |
| Acrivon Therapeutics Inc(ACRV) | COMMON STOCK | 004890109 | $3.3M | 284,201 | 3.0% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $3.3M | 3,880,900 | 3.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $2.9M | 110,000 | 2.6% |
| Conmed Corp(CNMD) | COM | 207410101 | $2.4M | 27,500 | 2.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $2.4M | 20,000 | 2.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $1.8M | 70,000 | 1.6% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $1.6M | 60,000 | 1.4% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $1.5M | 5,750 | 1.4% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $1.3M | 30,000 | 1.2% |
| Geron Corp(GERN) | COM | 374163103 | $1.2M | 500,000 | 1.1% |
| Penumbra Inc(PEN) | COM | 70975L107 | $1.1M | 5,000 | 1.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $978.5K | 50,000 | 0.9% |
| Rain Oncology Inc | COM | 75082Q105 | $960.0K | 120,000 | 0.9% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $881.6K | 3,500 | 0.8% |
| Silk RD MED Inc | COM | 82710M100 | $792.8K | 15,000 | 0.7% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $744.0K | 150,000 | 0.7% |
| Eqrx Inc | *W EXP 12/17/202 | 26886C115 | $9.5K | 35,239 | 0.0% |
| Eucrates Biomedical Acqu COR | *W EXP 10/23/202 | G3141W122 | $4.3K | 78,059 | 0.0% |
| Medicus Sciences Acquisition | *W EXP 02/12/202 | G5960S124 | $2.7K | 29,776 | 0.0% |